Answers are grounded in this paper and cite their sources.
Observational analysis shows boron neutron capture therapy may improve outcomes in nasopharyngeal carcinoma, suggesting new options for radiotherapy-resistant cases.
Background Boron Neutron Capture Therapy (BNCT) shows clinical promise for cancer treatment, particularly in addressing radiotherapy resistance, the primary cause of local recurrence in nasopharyngeal carcinoma (NPC). Research on BNCT for both conventional and radiotherapy-resistant NPC remains limited.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: